These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

650 related articles for article (PubMed ID: 33839482)

  • 1. How the COVID-19 Pandemic has changed multiple sclerosis clinical practice: Results of a nationwide provider survey.
    Morrison EH; Michtich K; Hersh CM
    Mult Scler Relat Disord; 2021 Jun; 51():102913. PubMed ID: 33839482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of COVID-19 on U.S. and Canadian neurologists' therapeutic approach to multiple sclerosis: a survey of knowledge, attitudes, and practices.
    Mateen FJ; Rezaei S; Alakel N; Gazdag B; Kumar AR; Vogel A
    J Neurol; 2020 Dec; 267(12):3467-3475. PubMed ID: 32638107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical course and outcome of SARS-CoV-2 infection in multiple sclerosis patients treated with disease-modifying therapies - the Polish experience.
    Czarnowska A; Brola W; Zajkowska O; Rusek S; Adamczyk-Sowa M; Kubicka-Bączyk K; Kalinowska-Łyszczarz A; Kania K; Słowik A; Wnuk M; Marona M; Podlecka-Piętowska A; Nojszewska M; Zakrzewska-Pniewska B; Jasińska E; Gołuch K; Lech B; Noga M; Perenc A; Popiel M; Lasek-Bal A; Puz P; Maciejowska K; Kucharska-Lipowska M; Lipowski M; Kapica-Topczewska K; Chorąży M; Tarasiuk J; Kochanowicz J; Kulikowska J; Wawrzyniak S; Niezgodzińska-Maciejek A; Pokryszko-Dragan A; Gruszka E; Budrewicz S; Białek M; Kurkowska-Jastrzębska I; Kurowska K; Stępień A; Włodek A; Ptasznik V; Pawełczyk M; Sobolewski P; Lejmel H; Strzalińska K; Maciejowski M; Tutaj A; Zwiernik J; Litwin A; Lewańczyk B; Paprocka I; Zwiernik B; Pawlos A; Borysowicz A; Narożnik A; Michałowska A; Nosek K; Fudala M; Milewska-Jędrzejczak M; Kułakowska A; Bartosik-Psujek H
    Neurol Neurochir Pol; 2021; 55(2):212-222. PubMed ID: 33856686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis.
    Simpson-Yap S; De Brouwer E; Kalincik T; Rijke N; Hillert JA; Walton C; Edan G; Moreau Y; Spelman T; Geys L; Parciak T; Gautrais C; Lazovski N; Pirmani A; Ardeshirdavanai A; Forsberg L; Glaser A; McBurney R; Schmidt H; Bergmann AB; Braune S; Stahmann A; Middleton R; Salter A; Fox RJ; van der Walt A; Butzkueven H; Alroughani R; Ozakbas S; Rojas JI; van der Mei I; Nag N; Ivanov R; Sciascia do Olival G; Dias AE; Magyari M; Brum D; Mendes MF; Alonso RN; Nicholas RS; Bauer J; Chertcoff AS; Zabalza A; Arrambide G; Fidao A; Comi G; Peeters L
    Neurology; 2021 Nov; 97(19):e1870-e1885. PubMed ID: 34610987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantifying the administration and monitoring time burden of several disease-modifying therapies for relapsing multiple sclerosis in the United Kingdom: A time and motion study.
    Rog D; Brownlee W; Carod-Artal FJ; Kalra S; Barker N; Lowndes C; Pendlebury J; Leclerc S; Amin A; Ashton L; Evans H; De Cock E
    Mult Scler Relat Disord; 2024 Feb; 82():105380. PubMed ID: 38183696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective study of cellular immune response to booster COVID-19 vaccination in multiple sclerosis patients treated with a broad spectrum of disease-modifying therapies.
    Torres P; Sancho-Saldaña A; Gil Sánchez A; Peralta S; Solana MJ; Bakkioui S; González-Mingot C; Quibus L; Ruiz-Fernández E; San Pedro-Murillo E; Brieva L
    J Neurol; 2023 May; 270(5):2380-2391. PubMed ID: 36933032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of COVID-19 infection and severe disease in MS patients on different disease-modifying therapies.
    Smith TE; Madhavan M; Gratch D; Patel A; Saha V; Sammarco C; Rimler Z; Zuniga G; Gragui D; Charvet L; Cutter G; Krupp L; Kister I; Ryerson LZ
    Mult Scler Relat Disord; 2022 Apr; 60():103735. PubMed ID: 35398713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Managing multiple sclerosis in the Covid19 era: a review of the literature and consensus report from a panel of experts in Saudi Arabia.
    Al Jumah M; Abulaban A; Aggad H; Al Bunyan R; AlKhawajah M; Al Malik Y; Almejally M; Alnajashi H; Alshamrani F; Bohlega S; Cupler EJ; ElBoghdady A; Makkawi S; Qureshi S; Shami S
    Mult Scler Relat Disord; 2021 Jun; 51():102925. PubMed ID: 33857897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of the COVID-19 pandemic on the health care of >1,000 People living with multiple sclerosis: A cross-sectional study.
    Vogel AC; Schmidt H; Loud S; McBurney R; Mateen FJ
    Mult Scler Relat Disord; 2020 Nov; 46():102512. PubMed ID: 32977074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perceptions of risk and adherence to care in MS patients during the COVID-19 pandemic: A cross-sectional study.
    Zhang Y; Staker E; Cutter G; Krieger S; Miller AE
    Mult Scler Relat Disord; 2021 May; 50():102856. PubMed ID: 33662858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indirect impact of the COVID-19 pandemic on the care and outcomes of people with MS: A combined survey and insurance claims study.
    Meltzer E; Charron O; Wozny J; Onuorah H; Montague A; Kline AC; Largent A; Krause TM; Freeman L
    Mult Scler Relat Disord; 2023 Dec; 80():105085. PubMed ID: 37931487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple sclerosis management during the COVID-19 pandemic.
    Moss BP; Mahajan KR; Bermel RA; Hellisz K; Hua LH; Hudec T; Husak S; McGinley MP; Ontaneda D; Wang Z; Weber M; Tagliani P; Cárdenas-Robledo S; Zabalza A; Arrambide G; Carbonell-Mirabent P; Rodríguez-Barranco M; Sastre-Garriga J; Tintore M; Montalban X; Douglas M; Ogbuokiri E; Aravidis B; Cohen JA; Mowry EM; Fitzgerald KC
    Mult Scler; 2020 Sep; 26(10):1163-1171. PubMed ID: 32772807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial experiences of US neurologists in practice during the COVID-19 pandemic via survey.
    Sharma A; Maxwell CR; Farmer J; Greene-Chandos D; LaFaver K; Benameur K
    Neurology; 2020 Aug; 95(5):215-220. PubMed ID: 32439820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The perspective of Canadian health care professionals on abortion service during the COVID-19 pandemic.
    Ennis M; Wahl K; Jeong D; Knight K; Renner R; Munro S; Dunn S; Guilbert E; Norman WV
    Fam Pract; 2021 Aug; 38(Suppl 1):i30-i36. PubMed ID: 34448482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the perspective of patients with MS and related conditions on their DMT in relation to the COVID-19 pandemic in one MS centre in Australia.
    Seery N; Li V; Nguyen AL; Roos I; Buzzard KA; Atvars R; Taylor N; Tunnell K; Carey J; Dwyer C; Taylor HFL; Baker J; Marriott MP; Kilpatrick TJ; Kalincik T; Monif M
    Mult Scler Relat Disord; 2020 Nov; 46():102516. PubMed ID: 32957057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementing Shared Decision-Making for Multiple Sclerosis: The MS-SUPPORT Tool.
    Col NF; Solomon AJ; Alvarez E; Pbert L; Ionete C; BerriosMorales I; Chester J; Kutz C; Iwuchukwu C; Livingston T; Springmann V; Col HV; Ngo LH
    Mult Scler Relat Disord; 2023 Dec; 80():105092. PubMed ID: 37931489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes on the health care of people with multiple sclerosis from Latin America during the COVID-19 pandemic.
    Chertcoff A; Bauer J; Silva BA; Aldecoa M; Eizaguirre MB; Rodriguez R; Chereque A; Rodríguez Heudebert ML; Milanesi V; Morales L; Castellón M; Mejía Pineda S; Ferrandina F; Henestroza P; Ruiz Peraza M; Vallecillo Rivas F; Cedeño Lopez L; Herrera L; Sosa M; Cruchet Muñoz V; Barahona AS; Ramírez Gudiño LM; Carballido S; Walton C; Peeters LM; Rijke N; Garcea O; Carrá A; Alonso R
    Mult Scler Relat Disord; 2021 Sep; 54():103120. PubMed ID: 34243104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of COVID-19 on prescribing patterns and treatment selection of disease modifying therapies in multiple sclerosis.
    Zaheer R; Amin R; Riddick L; Roy S; Wolff S; Nathanson A; Newsome S
    Mult Scler Relat Disord; 2023 Mar; 71():104575. PubMed ID: 36857853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment selection and experience in multiple sclerosis: survey of neurologists.
    Hanson KA; Agashivala N; Wyrwich KW; Raimundo K; Kim E; Brandes DW
    Patient Prefer Adherence; 2014; 8():415-22. PubMed ID: 24729689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protecting the front line: a cross-sectional survey analysis of the occupational factors contributing to healthcare workers' infection and psychological distress during the COVID-19 pandemic in the USA.
    Firew T; Sano ED; Lee JW; Flores S; Lang K; Salman K; Greene MC; Chang BP
    BMJ Open; 2020 Oct; 10(10):e042752. PubMed ID: 33087382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.